Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 8:06 p.m.

    📋 Instil Bio, Inc. (TIL) - Financial Results

    Filing Date: 2022-05-16

    Accepted: 2022-05-16 07:13:41

    Event Type: Financial Results

    Event Details:

    Instil Bio Inc (TIL) Reports Q2 2022 Financial Results Instil Bio Inc (TIL) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 379520
      • expected in 2023
      • Targeting completion of enrollment in registrational cohort of DELTA-1 in 2022
      • targeting completion of enrollment by 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Cash Equivalents Marketable Securities 379.52K 379.52K $0.00 +0.00%
    Operating Expenses Loss From Operations -54.29K -23.40K $-30.88K -131.96%
    Operating Expenses Net Loss -54.12K -54.12K $0.00 +0.00%
    Operating Expenses Net Loss Per Share -0.42 -0.42 $0.00 +0.00%
    Operating Expenses Weighted Average Shares 129.12M 34.98M $94.14M +269.16%
    Adjustments Net Loss Per Share -0.36 -0.36 $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Instil Bio Inc
    • CIK: 0001789769
    • Ticker Symbol: TIL
    • Period End Date: 2022-05-16
    • Document Type: 8-K

Search

News categories